Skip to content

KMTS KMTS EBITDA margin

EBITDA margin at other companies

Abbott logo
AbbottABT
24.1%-0.2pp
Boston Scientific logo
Boston ScientificBSX
25.2%+1.6pp
Medtronic logo
MedtronicMDT
25.9%-0.4pp
iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC
-2.9%-1.3pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
20.2%+0.9pp
Haemonetics logo
HaemoneticsHAE
27.6%+6.1pp

Other financials

Income statement

See full
Revenue$24.6M+62.7%
Gross profit$12.9M+97.1%
Operating income-$34.8M-68.8%
Net income-$34.2M-58.8%
EPS (diluted)-$0.61+51.2%

Balance sheet

See full
Cash & equivalents$291.3M+436%
Total debt$43.8M
Total assets$379.3M

Cash flow

See full
Operating cash flow-$18.4M-2.1%
CapEx$9.8M+141%
Free cash flow-$28.2M-27.7%

Valuation

See full
Market cap$1.29B+70.8%
Enterprise value$1.04B
P/S15.4×

Profitability

See full
Gross margin48.8%+15.1pp
Operating margin-171.5%+12.9pp
Net margin-173%+0.8pp
FCF margin-142.9%-25.3pp

Returns & leverage

See full
Current ratio7.3×

Where this comes from

Calculated from KMTS’s reported figures.

Based on trailing twelve months.

The official record: KMTS’s 10-Q, filed March 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about KMTS's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KMTS's EBITDA margin?
KMTS (KMTS) reported EBITDA margin of -161.7% in Q4 2025.
How has KMTS's EBITDA margin changed year-over-year?
KMTS's EBITDA margin decreased by 13.8% year-over-year, from -142.1% to -161.7%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.